Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,993,000 | 2,227,000 | 3,552,000 | 3,069,000 | 1,246,000 |
| Depreciation Amortization | 3,753,000 | 3,036,000 | 2,357,000 | 2,852,000 | 3,282,000 |
| Accounts receivable | -523,000 | 83,000 | 1,610,000 | 152,000 | 311,000 |
| Accounts payable and accrued liabilities | -103,000 | 415,000 | -341,000 | 114,000 | 2,089,000 |
| Other Working Capital | -639,000 | -50,000 | 926,000 | -49,000 | 2,508,000 |
| Other Operating Activity | -1,863,000 | -2,133,000 | -3,959,000 | -2,814,000 | -2,378,000 |
| Operating Cash Flow | $2,618,000 | $3,578,000 | $4,145,000 | $3,324,000 | $7,058,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 405,000 | -345,000 | -166,000 | 283,000 | 34,000 |
| PPE Investments | -1,031,000 | -1,243,000 | -1,364,000 | -1,281,000 | -854,000 |
| Net Acquisitions | -349,000 | -1,450,000 | -2,564,000 | -3,025,000 | -4,461,000 |
| Purchase Of Investment | -102,000 | -96,000 | -230,000 | -57,000 | -130,000 |
| Sale Of Investment | 24,000 | 70,000 | 3,000 | 93,000 | 59,000 |
| Purchase Sale Intangibles | 2,010,000 | 1,082,000 | 559,000 | -330,000 | -1,740,000 |
| Other Investing Activity | 2,016,000 | 736,000 | 352,000 | -252,000 | -1,680,000 |
| Investing Cash Flow | $963,000 | $-2,328,000 | $-3,969,000 | $-4,239,000 | $-7,032,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -98,000 | 336,000 | -303,000 | -630,000 | 520,000 |
| Debt Issued | 2,971,000 | 1,988,000 | 2,491,000 | 5,928,000 | 919,000 |
| Debt Repayment | -1,400,000 | -1,750,000 | N/A | -884,000 | -750,000 |
| Common Stock Issued | 34,000 | 43,000 | 47,000 | 43,000 | 279,000 |
| Dividend Paid | -3,484,000 | -3,519,000 | -3,561,000 | -3,486,000 | -3,521,000 |
| Other Financing Activity | -67,000 | -34,000 | 2,000 | -93,000 | -152,000 |
| Financing Cash Flow | $-2,044,000 | $-2,936,000 | $-1,324,000 | $878,000 | $-2,705,000 |
| Exchange Rate Effect | -38,000 | -66,000 | 21,000 | -76,000 | -152,000 |
| Beginning Cash Position | 3,172,000 | 4,924,000 | 6,051,000 | 6,164,000 | 8,995,000 |
| End Cash Position | 4,671,000 | 3,172,000 | 4,924,000 | 6,051,000 | 6,164,000 |
| Net Cash Flow | $1,499,000 | $-1,752,000 | $-1,127,000 | $-113,000 | $-2,831,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,618,000 | 3,578,000 | 4,145,000 | 3,324,000 | 7,058,000 |
| Capital Expenditure | -1,043,000 | -1,326,000 | -1,446,000 | -1,328,000 | -1,012,000 |
| Free Cash Flow | 1,575,000 | 2,252,000 | 2,699,000 | 1,996,000 | 6,046,000 |